2025
Impact of a novel oral medication delivery device on patient engagement and discontinuation in individuals receiving oral oncolytic medications.
Taylor M, Fuhr K, Heiland K, Huntington S, Lustberg M, Schellhorn S. Impact of a novel oral medication delivery device on patient engagement and discontinuation in individuals receiving oral oncolytic medications. Journal Of Clinical Oncology 2025, 43: 11063-11063. DOI: 10.1200/jco.2025.43.16_suppl.11063.Peer-Reviewed Original ResearchPatient-reported outcomesHistorical control groupDose reductionControl groupAdverse event-related discontinuationsEvaluate dose reductionMedication delivery devicesHistorical control cohortTime of dosingDelivery devicesRibociclib groupEarly toxicityDiscontinuation ratesMedian ageMedication toleranceAcute care utilizationClinical outcomesHistorical controlsOral medicationsRibociclibControl cohortTreatment adjustmentMedication discontinuationAcalabrutinibCohort of individuals
2019
Application of Parafilm As a Physical Barrier on CVC Connections Is Feasible and May Reduce Clabsi Among Pediatric HCT Patients
Stenger E, Newton J, Leong T, Kendrick L, McManus L, Rooke C, Krishnamurti L. Application of Parafilm As a Physical Barrier on CVC Connections Is Feasible and May Reduce Clabsi Among Pediatric HCT Patients. Transplantation And Cellular Therapy 2019, 25: s131. DOI: 10.1016/j.bbmt.2018.12.416.Peer-Reviewed Original ResearchPediatric HCT patientsCentral venous cathetersHCT patientsCLABSI ratesLong-term central venous cathetersExternal central venous cathetersPediatric patients ages 0Pilot quality improvement initiativeHematopoietic cell transplantation patientsYounger aged patientsHistorical control patientsPatients ages 0Cell transplantation patientsHistorical control groupNon-malignant diseasesQuality improvement initiativesCLABSI occurrenceCVC hubsHost diseaseProlonged immunosuppressionTransplantation patientsAutologous HCTCohort studyControl patientsHCT outcomes
2016
Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer.
Stein S, James E, Cong X, Deng Y, Salem R, Cha C, Chang B, Hochster H, Doddamane I, Boustani A, Patel V, Kortmansky J, Li J, Staugaard C, Lacy J. Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer. Journal Of Clinical Oncology 2016, 34: 395-395. DOI: 10.1200/jco.2016.34.4_suppl.395.Peer-Reviewed Original Research
2015
Atypical aortic arch branching variants: A novel marker for thoracic aortic disease
Dumfarth J, Chou AS, Ziganshin BA, Bhandari R, Peterss S, Tranquilli M, Mojibian H, Fang H, Rizzo JA, Elefteriades JA. Atypical aortic arch branching variants: A novel marker for thoracic aortic disease. Journal Of Thoracic And Cardiovascular Surgery 2015, 149: 1586-1592. PMID: 25802134, DOI: 10.1016/j.jtcvs.2015.02.019.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAneurysmAorta, ThoracicAortic DiseasesAortographyCardiovascular AbnormalitiesCase-Control StudiesConnecticutDeglutition DisordersFemaleHumansMaleMiddle AgedPredictive Value of TestsPrevalenceRisk FactorsSubclavian ArteryTime FactorsTomography, X-Ray ComputedVascular MalformationsVertebral ArteryConceptsThoracic aortic diseaseAberrant right subclavian arteryLeft vertebral arteryRight subclavian arteryBovine aortic archAortic arch variationsAortic archControl groupSubclavian arteryAortic diseaseVertebral arteryArch anatomyAortic branch variationsNormal arch anatomyBicuspid aortic valveHistorical control groupAortic arch variantsAortic arch anatomySignificant higher prevalenceChart reviewBranch patternAortic aneurysmAortic valveHigh prevalenceGeneral population
2011
Impact of an Educational Intervention on Caregivers’ Beliefs About Infant Crying and Knowledge of Shaken Baby Syndrome
Bechtel K, Le K, Martin KD, Shah N, Leventhal JM, Colson E. Impact of an Educational Intervention on Caregivers’ Beliefs About Infant Crying and Knowledge of Shaken Baby Syndrome. Academic Pediatrics 2011, 11: 481-486. PMID: 21940233, DOI: 10.1016/j.acap.2011.08.001.Peer-Reviewed Original ResearchConceptsShaken baby syndromeHospital dischargeIntervention groupEducational interventionAnticipatory guidanceUrban primary care centerPediatric residentsInfant cryingNewborn hospital dischargeHistorical control groupPrimary care centersIntervention group caregiversBeliefs/knowledgePostpartum interventionsCare centerAdjusted associationsInfant deathBaby syndromeShaken BabyHospital staffControl groupYoung infantsMore mothersInfantsLogistic regression
1998
Reduction in arteriovenous graft impairment: Results of a vascular access surveillance protocol
Cayco A, Abu-Alfa A, Mahnensmith R, Perazella M. Reduction in arteriovenous graft impairment: Results of a vascular access surveillance protocol. American Journal Of Kidney Diseases 1998, 32: 302-308. PMID: 9708617, DOI: 10.1053/ajkd.1998.v32.pm9708617.Peer-Reviewed Original ResearchConceptsDynamic venous pressureHistorical control groupVenous pressureArteriovenous graftsSurveillance protocolStudy groupBlood flow rateThrombosis rateControl groupSimilar historical control groupHemodialysis vascular accessSynthetic arteriovenous graftsLower thrombosis rateML/minGraft impairmentVenous stenosisHD sessionVascular accessVascular stenosisPatientsScreening testStenosisStudy periodFrustrating problemConsecutive readings
1987
Prolongation of survival for high-grade malignant gliomas with adjuvant high-dose BCNU and autologous bone marrow transplantation.
Johnson D, Thompson J, Corwin J, Mosley K, Smith M, de los Reyes R, Daly M, Petty A, Lamaster D, Pierson W. Prolongation of survival for high-grade malignant gliomas with adjuvant high-dose BCNU and autologous bone marrow transplantation. Journal Of Clinical Oncology 1987, 5: 783-9. PMID: 3553437, DOI: 10.1200/jco.1987.5.5.783.Peer-Reviewed Original ResearchConceptsAutologous bone marrow transplantationHigh-dose BCNUBone marrow transplantationSignificant survival advantageMarrow transplantationMedian survivalMalignant gliomasBone marrowSurvival advantageConsecutive historical control patientsDied of pulmonary hemorrhageWeeks of initial surgeryHigh-grade malignant gliomasBone marrow infusionProlongation of survivalPoor performance statusAbsolute granulocyte countHistorical control patientsAutologous bone marrowMalignant glial tumorsHistorical control groupEmpirical antibioticsBrain irradiationInitial surgeryMarrow infusion
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply